Want to see AU:NOX full AI Analyst Report?
Noxopharm Ltd. (NOX) Income Statement
Noxopharm Ltd. Income Statement
Last quarter (Q4 2026), Noxopharm Ltd.'s total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Noxopharm Ltd.'s net income was $-2.61M. See Noxopharm Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 1.43M | $ 2.82M | $ 2.40M | $ 6.01M | $ 5.43M | |
| $ -1.74K | $ -1.45M | $ -534.81K | $ 5.86M | $ 5.17M | |
| $ 4.85M | $ 8.21M | $ 7.00M | $ 16.44M | $ 14.95M | |
| Depreciation and Amortization | $ 1.74K | $ 1.74K | $ 1.74K | $ 154.53K | $ 261.51K |
| $ -4.85M | $ -5.38M | $ -5.95M | $ -20.85M | $ -23.70M | |
| $ -4.85M | $ -9.65M | $ -7.54M | $ -16.60M | $ -15.21M | |
| $ -1.04M | $ 4.77M | $ 1.56M | $ -4.45M | $ -8.83M | |
| $ -5.88M | $ -4.88M | $ -5.98M | $ -21.04M | $ -24.03M | |
| $ -4.46M | $ -4.88M | $ -3.58M | $ -15.06M | $ -18.67M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.01 | $ -0.02 | $ -0.01 | $ -0.05 | $ -0.06 |
| Diluted EPS | $ -0.01 | $ -0.02 | $ -0.01 | $ -0.05 | $ -0.06 |
| Weighted Average Shares Outstanding | 297.06M | 292.47M | 292.24M | 292.24M | 291.22M |
| Weighted Average Shares Outstanding (Diluted) | 297.06M | 292.47M | 292.24M | 292.24M | 291.22M |
Currency in AUD
